Perimed at Järfälla Näringsliv Webinar

Listen to Petri Markkanen COO of Perimed giving good advise on how to succeed in international business at Järfälla Näringsliv’s webinar together with representatives from Haglöf, Mousetrapper and Business Sweden.


300 PeriCam PSI delivered all over the world

Perimed has delivered more than 300 PeriCam PSI instruments to hospitals and clinics all over the world.

Watch the video to see how PeriCam PSI is used as an excellent tool to estimate burn depth and its value in predicting the healing capacity of a burn wound.

750 units of PeriFlux 6000 delivered worldwide

We are very proud to announce that we have sold the amazing number of 750 PeriFlux 6000 instruments worldwide to today’s date, and the latest unit was delivered to a well renowned clinic in the USA. The PeriFlux 6000 is the only system that performs a complete perfusion assessment in 20 minutes that meets the new Global Vascular Guidelines of CLTI. Take a look at the video and discover why PeriFlux 6000 is so unique.

Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model

Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model!

ESVS Industry Symposium 2020

Perimed presenting:
A complete perfusion assessment in 20 minutes that meets the new  Global Vascular Guidelines of CLTI on September 29 at 16:00.

Article in Dagens Medicin

Interesting article in Dagens Medicin:

Nytt sätt att mäta graden av kärlpåverkan


PAD User Forum postponed until further notice

Following the recent developments concerning the Coronavirus (COVID-19) situation, the

PAO User Forum hosted by Perimed and ESVSis hereby postponed.

Perimed was forced to take the tough decision to postpone this event due to the fact that many hospitals, companies, and other organizations have either advised against, or prohibited travel and attendance to international conferences.

We fully understand that this decision creates inconveniences to our participants, delegates and presenters and would like to sincerely apologize for this.

Naturally, we will keep you informed with further details regarding the new dates and place of the “PAD User Forum”.+

Radiometer partners with Perimed to improve wound care and hyperbaric diagnostics

The partnership between Radiometer and Perimed will give Radiometer the ability to sell Perimed’s unique wound care system and give Perimed the ability to expand the reach of their product through Radiometer’s strong distribution network.

Brønshøj, January 8, 2019. 10.00 CET
Radiometer Medical ApS (Radiometer) partners with Perimed AB (Perimed) to accelerate and expand the distribution of the Perimed PeriFlux 6000 tcpO2 standalone system. The partnership will combine Radiometer’s strong, direct and established commercial network with Perimed’s state-of-the-art system, thus allowing a wider range of customers and patients to benefit from the capabilities of the product.
“At Radiometer, our vision is to improve global healthcare with reliable, fast and easy diagnoses,” says Henrik Schimmell, President and CEO of Radiometer. “We strive hard to meet the needs and even surpass the expectations of our customers. The PeriFlux 6000 tcpO2 standalone system is the latest generation of transcutaneous monitoring and we’re excited to obtain the distribution rights of the device and further expand its position in the market.”
The Periflux 6000 tcpO2 standalone system will be an addition to Radiometer’s existing portfolio of transcutaneous monitoring systems, designed to provide non-invasive measurements of oxygenation status. The PeriFlux 6000 tcpO2 standalone system provides health care professionals with a reliable and easy tool to support wound healing predictions and will replace Radiometer’s TCM400.
“Perimed’s mission is to improve the quality of life for people suffering from vascular diseases, by supplying diagnostic instruments in the field of microcirculation and peripheral macro circulation,” says Björn Bakken, President of Perimed. “We have good products, but our sales capacity is limited. Radiometer’s sales capability and knowledge in tcpO2 is undisputed and we’re excited to have entered into this partnership. We hope this cooperation will lead to improved diagnostic capability in the wound care and hyperbaric sector.”
The PeriFlux 6000 tcpO2 standalone system will initially be launched in the US with other markets to follow. As part of the launch in the US, Radiometer will take over the support of Perimed’s existing and future users of the PeriFlux 6000 tcpO2 standalone.
Perimed will continue to sell and support all PeriFlux 6000 cart based systems that contains a PC, and measures toe-pressure, SPP, or tcpO2 in combination with Toe-pressure or SPP. Perimed will also continue to support the older PeriFlux 5000 Systems and the Perimed Imager range of instruments.

About Radiometer
Radiometer is a leading provider of technologically advanced acute care solutions that simplify and automate all phases of acute care testing.
Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related IT management systems.

About Perimed
Perimed is a world leader in developing, manufacturing and marketing state-of-the-art equipment for microvascular diagnosis.
Perimed provides instruments, software and expertise to enable assessment of the microcirculation. Through utilization of laser Doppler, laser speckle (LASCA) and transcutaneous oxygen (tcpO2 or TCOM), Perimed accurately monitor and quantify blood perfusion and tissue oxygenation in real-time.

Katrine Rørdam
Senior Manager, Communications & CSR, Radiometer ApS
+45 3029 3331

Björn Bakken
President, Perimed AB
+46 739 82 41 36